<DOC>
	<DOCNO>NCT00813618</DOCNO>
	<brief_summary>To assess safety escalate dose level MEDI-507 pediatric stem cell bone marrow allograft recipient least Grade II GvHD .</brief_summary>
	<brief_title>Study MEDI 507 Treatment Pediatric Patients</brief_title>
	<detailed_description>This Phase I , open-label dose escalation trial MEDI-507 pediatric SCT BMT recipient least Grade II acute GvHD . All patient receive steroid therapy MEDI-507 treatment GvHD</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Allogeneic BMT SCT recipient Acute GvHD least Grade II severity Age 2 17 year Evidence engraftment ( ANC 500 cells/mm3 two consecutive day within seven day study entry ) Receipt GvHD prophylaxis regimen include methotrexate , tacrolimus cyclosporine Receipt least 2 mg/kg methylprednisolone ( equivalent corticosteroid ) eight 24 hour prior first MEDI507 dose GvHD treatment Both males female eligible , sexually active female risk pregnancy childbearing potential must agree use effective method avoid pregnancy ( include oral implanted contraceptive , IUD , female condom , diaphragm spermicide , cervical cap , abstinence , use condom sexual partner sterile sexual partner ) begin 30 day first study infusion continue 60 day final study infusion . Treatment acute GvHD methylprednisolone ( equivalent corticosteroid ) total dose exceed 14 mg/kg ( equivalent ) seven day period ( example , 2 mg/kg/day seven day ) Previous receipt MEDI 507 Previous treatment antiT cell monoclonal antibody , OKT3 , daclizumab ( Zenapax ) , basiliximab ( Simulect ) Treatment antithymocyte globulin ( ATG , ATGAM others ) within 14 day More one allogeneic bone marrow hematopoietic stem cell allograft Use investigational agent within 30 day ( include use licensed agent indication list package insert ) current participation research protocol investigational agent administer Any follow clinical setting diagnosis : document presumed significant active infection pregnancy nurse mother evidence infection HIV1 , hepatitis B C virus hemodialysis chronic peritoneal dialysis use ventilator chronic GvHD active venoocclusive disease liver moribund patient</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Acute GvHD least Grade II severity</keyword>
</DOC>